Log in

Relevant bibliographies by topics / Beta-lactam antibiotic

Contents

Journal articles
Dissertations / Theses
Books
Book chapters
Conference papers
Reports

Academic literature on the topic 'Beta-lactam antibiotic'

Author: Grafiati

Published: 30 May 2022

Last updated: 31 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Beta-lactam antibiotic.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Beta-lactam antibiotic"

1

Bradley, Nicole, Yuman Lee, and Dana Weinstein. "Overview of Beta-Lactam Allergy and the Role of the Pharmacist in Management." Allergies 1, no. 2 (2021): 128–36. http://dx.doi.org/10.3390/allergies1020011.

Full text

Abstract:

Unverified beta-lactam allergies are a substantial public health problem, as the majority of patients labeled as beta-lactam allergic do not have clinically significant allergies that may hinder the use beta-lactam therapy when indicated. Outdated or inaccurate beta-lactam or penicillin allergies can result in serious consequences, including suboptimal antibiotic therapy, increased risk of adverse effects, and use of broader spectrum antibiotics than indicated, which may contribute to antimicrobial resistance. The purpose of this review is to provide an overview of beta-lactam allergy and high

APA, Harvard, Vancouver, ISO, and other styles

2

Asham, Preet Saini1 Shivam Sharma2 Tarun Sharma3 Kailash Singh Bisht*4. "Evaluation And Management Strategies for Beta-Lactam Antibiotics Induced Hypersensitivity Reactions: A Comprehensive Review." International Journal of Pharmaceutical Sciences 3, no. 3 (2025): 3188–206. https://doi.org/10.5281/zenodo.15110977.

Full text

Abstract:

Beta-lactam antibiotics are essential and extensively utilized medications for bacterial infections in clinical settings. Penicillin has the highest prevalence of inducing hypersensitivity reactions among beta-lactam antibiotics. This can lead to poor treatment outcomes, increased risk for antibiotic resistance, and high treatment expenses. With an increasing number of suspected cases of hypersensitivity reactions, it is essential to accurately diagnose them using sensitive skin testing and in-vitro methods, while minimizing the risk of serious adverse reactions. A thorough evaluation could ef

APA, Harvard, Vancouver, ISO, and other styles

3

Wieringa, André, Tim M. J. Ewoldt, Ravish N. Gangapersad, et al. "Predicting Beta-Lactam Target Non-Attainment in ICU Patients at Treatment Initiation: Development and External Validation of Three Novel (Machine Learning) Models." Antibiotics 12, no. 12 (2023): 1674. http://dx.doi.org/10.3390/antibiotics12121674.

Full text

Abstract:

In the intensive care unit (ICU), infection-related mortality is high. Although adequate antibiotic treatment is essential in infections, beta-lactam target non-attainment occurs in up to 45% of ICU patients, which is associated with a lower likelihood of clinical success. To optimize antibiotic treatment, we aimed to develop beta-lactam target non-attainment prediction models in ICU patients. Patients from two multicenter studies were included, with intravenous intermittent beta-lactam antibiotics administered and blood samples drawn within 12–36 h after antibiotic initiation. Beta-lactam tar

APA, Harvard, Vancouver, ISO, and other styles

4

Dhaese, Sofie A. M., Eric A. Hoste, and Jan J. De Waele. "Why We May Need Higher Doses of Beta-Lactam Antibiotics: Introducing the ‘Maximum Tolerable Dose’." Antibiotics 11, no. 7 (2022): 889. http://dx.doi.org/10.3390/antibiotics11070889.

Full text

Abstract:

The surge in antimicrobial resistance and the limited availability of new antimicrobial drugs has fueled the interest in optimizing antibiotic dosing. An ideal dosing regimen leads to maximal bacterial cell kill, whilst minimizing the risk of toxicity or antimicrobial resistance. For beta-lactam antibiotics specifically, PK/PD-based considerations have led to the widespread adoption of prolonged infusion. The rationale behind prolonged infusion is increasing the percentage of time the beta-lactam antibiotic concentration remains above the minimal inhibitory concentration (%fT>MIC). The ulti

APA, Harvard, Vancouver, ISO, and other styles

5

Ji, Youqi, Yinhuan Wang, Zhangkai Xu та ін. "Small Molecules from Medicinal Plant Iris tectorum as Histidine Kinase Inhibitor to Resensitize β-Lactam-Resistant Escherichia coli". Molecules 30, № 3 (2025): 663. https://doi.org/10.3390/molecules30030663.

Full text

Abstract:

Background: Due to the widespread use of broad-spectrum antibiotics, the problem of antibiotic resistance has become an increasingly serious global threat. One of the key mechanisms of Escherichia coli resistance to beta-lactam antibiotics is the production of beta-lactamase enzymes, which poses a dilemma for clinicians in selecting antibiotics when faced with resistant bacterial infections. However, research on the reversal of bacterial resistance is limited. Methods: This study involved the preparation of Iris tectorum extract and detection of its effects on antibiotics sensitivity, extended

APA, Harvard, Vancouver, ISO, and other styles

6

Gozali, Cynthia, and Conny Riana Tjampakasari. "Pseudomonas aeruginosa biofilm formation and its resistance to beta-lactam antibiotics." Damianus Journal of Medicine 22, no. 2 (2023): 162–72. http://dx.doi.org/10.25170/djm.v22i2.3928.

Full text

Abstract:

ABSTRACT Introduction: An opportunistic pathogen, Pseudomonas aeruginosa is a Gram-negative bacteria that causes acute and chronic human infections. By adhering to appropriate surfaces and creating a biofilm matrix, Pseudomonas aeruginosa has a high-resistance structure. Due to biofilm resistance mechanisms, this bacterial biofilm may increase natural antibiotic resistance. Antibiotics have difficulty penetrating the exopolysaccharide matrix that makes up the biofilm structure (Psl, Pe, alginate, and eDNA). Alginate is involved in generating mucus, and Psl and Pel components are implicated in

APA, Harvard, Vancouver, ISO, and other styles

7

Legg, Amy, Sinead Carmichael, Ming G. Chai, Jason A. Roberts, and Menino O. Cotta. "Beta-Lactam Dose Optimisation in the Intensive Care Unit: Targets, Therapeutic Drug Monitoring and Toxicity." Antibiotics 12, no. 5 (2023): 870. http://dx.doi.org/10.3390/antibiotics12050870.

Full text

Abstract:

Beta-lactams are an important family of antibiotics used to treat infections and are commonly used in critically ill patients. Optimal use of these drugs in the intensive care unit (ICU) is important because of the serious complications from sepsis. Target beta-lactam antibiotic exposures may be chosen using fundamental principles of beta-lactam activity derived from pre-clinical and clinical studies, although the debate regarding optimal beta-lactam exposure targets is ongoing. Attainment of target exposures in the ICU requires overcoming significant pharmacokinetic (PK) and pharmacodynamic (

APA, Harvard, Vancouver, ISO, and other styles

8

Krey, Steven C., Jeff Waise, and Lee P. Skrupky. "Confronting the Challenge of Beta-Lactam Allergies: A Quasi-Experimental Study Assessing Impact of Pharmacy-Led Interventions." Journal of Pharmacy Practice 32, no. 2 (2017): 139–46. http://dx.doi.org/10.1177/0897190017743154.

Full text

Abstract:

Objective: To improve allergy history documentation and increase the use of beta-lactams when appropriate in patients with a reported beta-lactam allergy. Methods: This pre–post study was conducted at a 167-bed tertiary care community hospital and evaluated multidisciplinary interventions on allergy documentation and antibiotic selection. Interventions included education, creation of local practice guidelines, and modified practices for pharmacists and pharmacy technicians. Inpatients with a reported beta-lactam allergy receiving at least 1 antibiotic for >24 hours were included; first admi

APA, Harvard, Vancouver, ISO, and other styles

9

Abd, Luma Salman. "Historical Review of the Penicillin and Related Compounds (β – Lactams)". Al Mustansiriyah Journal of Pharmaceutical Sciences 18, № 1 (2018): 109–27. http://dx.doi.org/10.32947/ajps.v18i1.464.

Full text

Abstract:

In spite of the old age of beta lactam, they continue to provide good health and preventing human diseases by virtue of industrial production and discoveries of small new beta-lactam group of secondary metabolite. Antibiotic resistance in bacteria has become a serious problem worldwide therefore, the present survey discusses the event that occurred in the progress of the penicillin, and beta-lactam from discovery to implementation as a therapeutic agent in order to overcome this issue . Moreover, this review provides a descriptive overview of the various published ways to enhance the clinical

APA, Harvard, Vancouver, ISO, and other styles

10

Semizhon, P. A., H. P. Scheslenok, I. V. Harbachova, I. I. Vashkevich, and O. V. Sviridov. "MONITORING OF BIOLOGICAL ACTIVITY OF BETA-LACTAM ANTIBIOTICS RECEPTOR BLAR-CTD IN THE PROCESSES OF ITS HETEROLOGICAL EXPRESSION, PURIFICATION AND APPLICATION IN ANALYTICAL SYSTEMS." http://eng.biomos.ru/conference/articles.htm 1, no. 19 (2021): 246–48. http://dx.doi.org/10.37747/2312-640x-2021-19-246-248.

Full text

Abstract:

To develop the technologies of beta-lactam antibiotics bioassays in foods, high purity beta-lactam receptor BlaR-CTD has been obtained and characterized. A test system for the quantitation of the biologically active and immunoreactive receptor in the processes of its heterological expression, isolation and reagent forms preparation was elaborated. The immunochemical properties and antibiotic binding ability of BlaR-CTD were investigated, and the constructions and application procedures of receptor-immune systems for the assay of beta-lactam antibiotics using microplates or chromatographic test

APA, Harvard, Vancouver, ISO, and other styles

More sources

Dissertations / Theses on the topic "Beta-lactam antibiotic"

1

Sayer, P. "The synthesis of #beta#-lactam antibiotic analogues." Thesis, Lancaster University, 1987. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.235587.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Rogers, M. E. "Beta-lactam antibiotics : Analysis and biosynthesis." Thesis, University of Westminster, 1986. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.383031.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

King, Dustin T. "Protecting our beta-lactam antibiotic assets : structural investigation of beta-lactamases." Thesis, University of British Columbia, 2016. http://hdl.handle.net/2429/56341.

Full text

Abstract:

Bacterial diseases have an enormous impact on human health. The most widespread class of human antibacterials is the β-lactams that target the transpeptidase activity of penicillin-binding proteins, which are responsible for cross-linking the peptidoglycan cell-wall. However, bacteria have gained resistance to all major classes of β-lactams. To protect the clinical utility of the β-lactams it is essential to understand the structural basis for this resistance. This thesis aims to better understand the molecular details governing extended-spectrum β-lactamase mediated β-lactam resistance, and t

APA, Harvard, Vancouver, ISO, and other styles

4

Vasilenko, Sofia, and Софія Василенко. "Bacteria resistance to beta-lactam antibiotics." Thesis, National Aviation University, 2021. https://er.nau.edu.ua/handle/NAU/50637.

Full text

Abstract:

1. Pulok K. Mukherjee. Quality Control and Evaluation of Herbal Drugs: Evaluating Natural Products and Traditional Medicine. Elsevier, 2019. 762 p. 2. Kumar A., Schweizer H. Bacterial resistance to antibiotics: Active efflux and reduced uptake. Adv. Drug Deliv. Rev. 2005. Vol. 57. P. 513. 3. Antimicrobial Resistance: Tackling a Crisis for the Future Health and Wealth of Nations. Chaired by Jim O’Neill. London: Review on Antimicrobial Resistance. 2014. 16 p. 4. Thomas C. M., Nielsen K.M. Mechanisms of, and barriers to, horizontal gene transfer between bacteria. Nat. Rev. Microbiol. 2005. Vol. 3

APA, Harvard, Vancouver, ISO, and other styles

5

Bening, Sarah Christine. "Exploring and enhancing context-dependent beta-lactam antibiotic efficacy." Thesis, Massachusetts Institute of Technology, 2021. https://hdl.handle.net/1721.1/130805.

Full text

Abstract:

Thesis: Ph. D., Massachusetts Institute of Technology, Department of Biological Engineering, February, 2021<br>Cataloged from the official PDF version of thesis.<br>Includes bibliographical references (pages 77-89).<br>Antibiotics, such as beta-lactams, are essential medical tools for the treatment of bacterial infections. Unfortunately, clinical treatment efficacy is declining over time as bacteria adapt to and evade antibiotic treatment through mechanisms called antibiotic resistance, tolerance, and persistence. Antibiotic tolerance and persistence, in particular, are often context-dependent

APA, Harvard, Vancouver, ISO, and other styles

6

Wallace, Jeremy Iain. "Hyperinducible Î²-lactamase expression in gram-negative bacteria." Thesis, University of Bristol, 1995. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.295568.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Turner, Philip J. "The in-vitro sensitivity testing of beta-lactam antibiotic combinations." Thesis, Aston University, 1985. http://publications.aston.ac.uk/12477/.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Korir, Cindy Chepngeno. "Biochemical and molecular characterization of streptococcus pneumoniae strains resistant to beta-lactam antibiotics." Diss., Available online, Georgia Institute of Technology, 2004:, 2004. http://etd.gatech.edu/theses/available/etd-07062004-081519/unrestricted/korir%5Fcindy%5Fc%5F200407%5Fphd.pdf.

Full text

Abstract:

Thesis (Ph. D.)--School of Biology, Georgia Institute of Technology, 2005. Directed by Paul Edmonds.<br>Paul Edmonds, Committee Chair ; Steve Harvey, Committee Member ; Igor Zhulin, Committee Member ; Yury Chernoff, Committee Member ; Mostafa El-Sayed, Committee Member. Includes bibliographical references.

APA, Harvard, Vancouver, ISO, and other styles

9

Saunders, Geoffrey Lance. "Beta-lactam antibiotic resistance in enterobacter cloacae isolated from Groot Schuur Hospital inpatients." Thesis, University of Cape Town, 1991. http://hdl.handle.net/11427/25559.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Saunders, G. L. (Geoffrey Lance). "Beta-lactam antibiotic resistance in enterobacter cloacae isolated from Groot Schuur Hospital inpatients." Master's thesis, University of Cape Town, 1991. http://hdl.handle.net/11427/25557.

Full text

APA, Harvard, Vancouver, ISO, and other styles

More sources

Books on the topic "Beta-lactam antibiotic"

1

Hamao, Umezawa, Takeda Kagaku Shinkō Zaidan, and Takeda Science Foundation Symposium (4th : 1986 : Kyoto, Japan), eds. Frontiers of antibiotic research. Academic Press, 1987.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

2

Turner, Philip John. The in-vitro sensitivity testing of beta-lactam antibiotic combinations. University of Aston.Department of Pharmacy, 1985.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

3

1935-, Tipper Donald J., ed. Antibiotic inhibitorsof bacterial cell wall biosynthesis. Pergamon, 1987.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

4

1935-, Tipper Donald J., ed. Antibiotic inhibitors of bacterial cell wall biosynthesis. Pergamon Press, 1987.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

5

F, Queener Sherry, Webber J. Alan 1940-, and Queener Stephen W, eds. Beta-lactam antibiotics for clinical use. M. Dekker, 1986.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

6

M, Livermore D., ed. The Clinical importance of beta-lactam resistance. Vieweg, 1990.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

7

Susumu, Mitsuhashi, and Franceschi G, eds. Penem antibiotics: FCE 22101 and its orally absorbed ester FCE 22891. Japan Scientific Societies Press, 1991.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

8

Bellido, F. The new -lactams: Mode of action, mechanisms of resistance. Roche, 1989.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

9

Bolister, Nina Jane. The diffusion of beta-lactam antibiotics through biopolymers. Brighton Polytechnic Department ofPharmacy, 1989.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

10

Alle, Bruggink, ed. Synthesis of [beta]-lactam antibiotics: Chemistry, biocatalysis & process integration. Kluwer Academic Publishers, 2001.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

More sources

Book chapters on the topic "Beta-lactam antibiotic"

1

Page, Malcolm G. P. "Beta-Lactam Antibiotics." In Antibiotic Discovery and Development. Springer US, 2011. http://dx.doi.org/10.1007/978-1-4614-1400-1_3.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Khan, Irfan Ahmad. "Newer Antibiotic Agents in Pipeline." In Beta-Lactam Resistance in Gram-Negative Bacteria. Springer Nature Singapore, 2022. http://dx.doi.org/10.1007/978-981-16-9097-6_18.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Singh, Anuradha, Mohammad Shahid, Parvez Anwar Khan, Haris M. Khan, and Hiba Sami. "An Overview on Antibiotic Resistance in Gram-Negative Bacteria." In Beta-Lactam Resistance in Gram-Negative Bacteria. Springer Nature Singapore, 2022. http://dx.doi.org/10.1007/978-981-16-9097-6_1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Sami, Hiba, Parvez Anwar Khan, and Anuradha Singh. "Transposons Associated with Antibiotic-Resistant Genes in Gram-Negative Bacteria." In Beta-Lactam Resistance in Gram-Negative Bacteria. Springer Nature Singapore, 2022. http://dx.doi.org/10.1007/978-981-16-9097-6_10.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Watanabe, Kunitomo, and Kazue Ueno. "Transfer of Beta-Lactam Antibiotic Resistance in Bacteroides." In Brock/Springer Series in Contemporary Bioscience. Springer New York, 1993. http://dx.doi.org/10.1007/978-1-4615-7087-5_36.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Farhat, Nabeela, and Asad U. Khan. "β-Lactamase Inhibitor Combinations Targeting Antibiotic Resistance in Gram-Negative Bacteria." In Beta-Lactam Resistance in Gram-Negative Bacteria. Springer Nature Singapore, 2022. http://dx.doi.org/10.1007/978-981-16-9097-6_16.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Ahmad, Iqbal, Shirjeel Ahmad Siddiqui, Samreen, Kirti Suman, and Faizan Abul Qais. "Environmental Biofilms as Reservoir of Antibiotic Resistance and Hotspot for Genetic Exchange in Bacteria." In Beta-Lactam Resistance in Gram-Negative Bacteria. Springer Nature Singapore, 2022. http://dx.doi.org/10.1007/978-981-16-9097-6_15.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Danziger, Larry H., and Melinda Neuhauser. "Beta-Lactam Antibiotics." In Drug Interactions in Infectious Diseases. Humana Press, 2011. http://dx.doi.org/10.1007/978-1-61779-213-7_7.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Danziger, Larry H., and Karolyn S. Horn. "Beta-Lactam Antibiotics." In Drug Interactions in Infectious Diseases: Antimicrobial Drug Interactions. Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-319-72416-4_1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Cojocel, Constantin. "Beta-lactam antibiotics." In Clinical Nephrotoxins. Springer US, 2008. http://dx.doi.org/10.1007/978-0-387-84843-3_13.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Beta-lactam antibiotic"

1

Guerrero, Gloria Ortiz, Vishal Shah, and Utku Uysal. "Clinical and Electrographic Features in Beta-Lactam Antibiotic Induced Neurotoxicity (P3-1.012)." In 2023 Annual Meeting Abstracts. Lippincott Williams & Wilkins, 2023. http://dx.doi.org/10.1212/wnl.0000000000204062.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Muntyan, Victoria S., Mariia E. Vladimirova, Alexey M. Afonin, Alexey N. Muntyan, and Marina L. Roumiantseva. "ANALYSIS OF SALT-SENSITIVE AND SALT-TOLERANT SINORHIZOBIUM MELILOTI STRAINS USING DNA MICROARRAY, PHENOTYPE MICROARRAY AND GENOME MINING TECHNIQUES." In 23rd SGEM International Multidisciplinary Scientific GeoConference 2023. STEF92 Technology, 2023. http://dx.doi.org/10.5593/sgem2023/6.1/s25.15.

Full text

Abstract:

Nodule bacteria increase the resistance of host plants to abiotic stress factors; however, the role of the genetic potential of rhizobia in the formation of productive salt-tolerant plant-microbial symbiosis remains underestimated. The aim of the study was to evaluate the pool of genes responsible for the salt tolerance of the alfalfa microsymbiont, Sinorhizobium meliloti, using the DNA microarray technique, phenotype microarray (PM), NGS and NNGS-technologies and genome mining (antismash 5.0). As a result of the analysis of the genomes of strains contrastingly different in salt tolerance, it

APA, Harvard, Vancouver, ISO, and other styles

3

Islam, Zainul, Septianita Hastuti, and Nadya Firstiana. "Analysis of Cost Effectiveness of Beta–Lactam Antibiotics in Child Pneumonia Patients." In Proceedings of the 1st International Conference on Economic and Education, ICON 2021, 14 - 15 December 2021, Padang-West Sumatra, Indonesia. EAI, 2022. http://dx.doi.org/10.4108/eai.14-12-2021.2318538.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

"Molecular composition - inhibition activity relationships for humic substances narrow fractions sets obtained by solid-phase extraction." In Sixth International Conference on Humic Innovative Technologies "Humic Substances and Eco-Adaptive Technologies ”(HIT – 2021). Non-Commercial Partnership "Center for Biogenic Resources "Humus Sapiens" (NP CBR "Humus Sapiens"), 2021. http://dx.doi.org/10.36291/hit.2021.mikhnevich.001.

Full text

Abstract:

Humic substances (HS) have a wide spectrum of biological activity including inhibitory activity against β-lactamases.1 The latter are capable of hydrolyzing beta-lactam antibiotics and represent one of the main pathways of bacterial antibiotic resistance. HS are characterized by low toxicity and good solubility in water. A use of HS for therapeutic purposes is hindered by extreme molecular heterogeneity and high level of isomeric complexity. Solid-phase extraction (SPE) fractionation in combination with ultra-high resolution mass spectrometry (FTICR MS) is a promising method to simplify this m

APA, Harvard, Vancouver, ISO, and other styles

5

Luo, Qijian, and Yiqi JIn. "Oral Beta-lactamase Protects the Gut Bifidobacterium/Lactobacillus from Beta-lactam Antibiotics-mediated Damage in SD Rats." In ICBBS '20: 2020 9th International Conference on Bioinformatics and Biomedical Science. ACM, 2020. http://dx.doi.org/10.1145/3431943.3431948.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Núñez-Núñez, M., R. Morón-Romero, R. Álvarez-Sánchez, et al. "4CPS-048 Beta-lactam antibiotics in critical ill patients: are we dosing our patients correctly?" In 25th EAHP Congress, 25th–27th March 2020, Gothenburg, Sweden. British Medical Journal Publishing Group, 2020. http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.149.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Horn, M., S. Micek, and M. H. Kollef. "Use of Beta-lactam Antibiotics in the Management of Sepsis in the Intensive Care Unit." In American Thoracic Society 2023 International Conference, May 19-24, 2023 - Washington, DC. American Thoracic Society, 2023. http://dx.doi.org/10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a3434.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Al – Rubaye, Talib, Samia Mahamoud, Aida Ibrahim, and Dalal AL-Rubaye. "Phenotypic and Genotypic Screening of Extended-Spectrum Beta-Lactamase-Producing Escherichia Coli Isolated from a Sample of Patients with Community-Acquired Urinary Tract Infection." In 5th International Conference on Biomedical and Health Sciences. Cihan University-Erbil, 2024. http://dx.doi.org/10.24086/biohs2024/paper.1336.

Full text

Abstract:

The bacteria Escherichia coli is the most common community-acquired urinary tract infection (UTI) pathogen, which is responsible for 75%–95% of cases, and due to the extensive use of β-lactam antibiotics in clinical cases, Extended- spectrum beta-lactamase (ESBLs) producing Escherichia coli have emerged. This study was done to isolate and identify Escherichia coli in a sample of Iraqi patients with a community- acquired urinary tract infection (CA-UTIs), the ESBL-producing E. coli was characterized phenotypically and genotypically. About 120 urine samples were collected from September 2022 to

APA, Harvard, Vancouver, ISO, and other styles

9

Đekić-Malbaša, Jelena, Tomi Kovačević, Branislav Tušek, Dunja Tušek, and Ana Milenković. "Clostridioides difficile infections in hospitalized lung diseases patients." In Proceedings of the International Congress Public Health - Achievements and Challenges. Institute of Public Health of Serbia "Dr Milan Jovanović Batut", 2024. http://dx.doi.org/10.5937/batutphco24117d.

Full text

Abstract:

Background: Clostridioides difficile infection (CDI), one of the most common healthcare-associated (HCA) infections, primarily affect the elderly and immune-compromised patients following antimicrobial consumption. Methods and Objectives: The aim was to determine the HCA CDI incidence trend, characteristics of patients, and classes of previously used antibiotics in the Institute for Pulmonary Diseases of Vojvodina (IPBV) from 2015 to 2023. The incidence of HCA CDI was calculated per 1,000 hospital admissions. Retrospective analysis of demographic and clinical characteristics of HCA CDI patient

APA, Harvard, Vancouver, ISO, and other styles

10

Pareek, Chandresh. "An Efficient Combinatorial Approach for Beta-Lactam Antibiotics with Novel Adjuvants against Gram-Negative Organisms to Combat Multi-Drug Resistance." In International conference on Applied Research in Engineering, Science and Technology. ACAVENT, 2018. http://dx.doi.org/10.33422/icarest.2018.09.47.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Beta-lactam antibiotic"

1

Chiu, Chia-Yu, and Amara Sarwal. Impact of area under the curve-based vancomycin dosing combination with anti-pseudomonal beta-lactam antibiotics: a systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2022. http://dx.doi.org/10.37766/inplasy2022.12.0025.

Full text

Abstract:

Review question / Objective: Did AUC-based vancomycin dosing reduce acute kidney injury than trough-based dosing when combined with anti-pseudomonal beta-lactam antibiotic? Condition being studied: Patients received Vancomycin combined with anti-pseudomonal beta-lactam antibiotics and monitor with either trough-base dosing or AUC-based dosing vancomycin. Information sources: All study types except case reports, case series, and conference abstracts were considered. PubMed, Embase, Cochrane Library, and ClinicalTrials.gov were searched from inception to November2022.

APA, Harvard, Vancouver, ISO, and other styles

2

Dou, Q. P. Synthetic Beta-Lactam Antibiotics as a Selective Breast Cancer Cell Apoptosis Inducer: Significance in Breast Cancer Prevention and Treatment. Defense Technical Information Center, 2007. http://dx.doi.org/10.21236/ada572620.

Full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!